**Use of Ceftobiprole for ComplicatedStaphylococcus aureusBacteremia**

Scott, Jake MD

Clinical Assistant Professor, Infectious Diseases and Geographic Medicine, Stanford University School of Medicine; Antimicrobial Stewardship Program Medical Director, Stanford Health Care Tri-Valley

Infectious Disease Alert 43(2):p 19-21, November 2023.

SYNOPSIS: In a randomized controlled trial conducted by Holland and colleagues, no significant difference in overall treatment success of complicated Staphylococcus aureus bacteremia was observed in patients who received ceftobiprole as compared with patients who received daptomycin.

SOURCE: Holland TL, Cosgrove SE, Doernberg SB, et al. Ceftobiprole for treatment of complicated Staphylococcus aureus bacteremia. N Engl J Med 2023;389:1390-1401.